Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach
The coronavirus disease 19 (COVID-19) is a highly contagious and rapidly spreading infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In some cases, the disease can be fatal which resulted in more than one million deaths worldwide according the WHO. Currently, ther...
Main Authors: | Jihane Akachar, El Mehdi Bouricha, Mohammed Hakmi, Lahcen Belyamani, Rachid El Jaoudi, Azeddine Ibrahimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844020325822 |
Similar Items
-
SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species
by: Santiago Rendon-Marin, et al.
Published: (2021-02-01) -
In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches
by: Alonso Vivar-Sierra, et al.
Published: (2021-01-01) -
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
by: Mushtaq Hussain, et al.
Published: (2020-09-01) -
In silico Molecular Docking Analysis Targeting SARSCoV-2 Spike Protein and Selected Herbal Constituents
by: Anbazhagan Subbaiyan, et al.
Published: (2020-05-01) -
Identification of Potential Semisynthetic Andrographolide Derivatives to Combat COVID-19 by Targeting the SARS-COV-2 Spike Protein and Human ACE2 Receptor– An In-silico Approach
by: Ravichandran, V.
Published: (2023)